COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 15 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,986,000 | – | 235,092 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 577,909 | $4,686,842 | 9.21% |
| VILLERE ST DENIS J & CO LLC | 292,723 | $2,388,619 | 0.17% |
| PINNACLE ASSOCIATES LTD | 484,653 | $3,954,768 | 0.07% |
| FNY Investment Advisers, LLC | 1,539 | $12 | 0.02% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 49,210 | $399 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,171 | $187,917 | 0.00% |
| BROWN ADVISORY INC | 73,849 | $602,608 | 0.00% |
| Geneos Wealth Management Inc. | 750 | $6,083 | 0.00% |
| Focused Wealth Management, Inc | 242 | $1,975 | 0.00% |
| UBS Group AG | 6,548 | $53,432 | 0.00% |